Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2008-N-0038]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2009. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the 
                        **Federal Register**
                        . This publication implements the IOM's recommendation.
 FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.


SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, undertook a study of the use of the FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the 
                    **Federal Register**
                    ; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the 
                    **Federal Register**
                    . However, changes to the schedule will be posted on the FDA 
                    ( print page 1691)
                    advisory committees' Internet site located at 
                    *http://www.fda.gov/​oc/​advisory/​default.htm*. FDA will continue to publish a 
                    **Federal Register**
                     notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20). The following list announces FDA's tentatively scheduled advisory committee meetings for 2009. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). Committee Name
Tentative Date of Meeting(s)
Advisory Committee 10-Digit Information Line CodeOFFICE OF THE COMMISSIONERPediatric Advisory Committee
March 23-24, June 22-23, September 21-22, December 7-8
8732310001Risk Communication Advisory Committee
February 26-27, April 30-May 1, August 13-14, November 12-13
8732112560Science Board to the Food and Drug Administration
February 24, May 18, August 17, November 16
3014512603CENTER FOR BIOLOGICS EVALUATION AND RESEARCHAllergenic Products Advisory Committee
March 5, October 22
3014512388Blood Products Advisory Committee
January 9, April 1, July 20-21, November 16-17
3014519516Cellular, Tissue and Gene Therapies Advisory Committee
May 14-15, November 5-6
3014512389Transmissible Spongiform Encephalopathies Advisory Committee
To be announced
3014512392Vaccines and Related Biological Products Advisory Committee
February 18-19, May 20-21, September 23-24, November 18-19
3014512391CENTER FOR DRUG EVALUATION AND RESEARCHAnesthetic and Life Support Drugs Advisory Committee
January 29-30, April dates to be announced
3014512529Anti-Infective Drugs Advisory Committee
To be announced
3014512530Antiviral Drugs Advisory Committee
To be announced
3014512531Arthritis Advisory Committee
March 5, June 16-17, October 27-28
3014512532Cardiovascular and Renal Drugs Advisory Committee
February 3, March 18-19, July 28-29, December 7-8
3014512533Dermatologic and Ophthalmic Drugs Advisory Committee
To be announced
3014512534Drug Safety and Risk Management Advisory Committee
January 30, April dates to be announced
3014512535Endocrinologic and Metabolic Drugs Advisory Committee
April 2-3
3014512536Gastrointestinal Drugs Advisory Committee
February 17
3014512538Nonprescription Drugs Advisory Committee
April dates to be announced
3014512541Oncologic Drugs Advisory Committee
February 25, March 24-25, May dates to be announced, July 14-15, September 15-16, December 16-17
3014512542Peripheral and Central Nervous System Drugs Advisory Committee
January 7-8
3014512543Pharmaceutical Science and Clinical Pharmacology, Advisory Committee for
March dates to be announced
3014512539Psychopharmacologic Drugs Advisory Committee
March 26
3014512544Pulmonary-Allergy Drugs Advisory Committee
February 4
3014512545Reproductive Health Drugs, Advisory Committee for
May and August dates to be announced
3014512537CENTER FOR DEVICES AND RADIOLOGICAL HEALTHDevice Good Manufacturing Practice Advisory Committee
April 15, October 5-6
3014512398Medical Devices Advisory Committee (Comprised of 18 Panels)( print page 1692)Anesthesiology and Respiratory Therapy Devices Panel
February 5, April 30, July 23, September 17, November 12
3014512624Circulatory System Devices Panel
February 25, May 27, September 24
3014512625Clinical Chemistry and Clinical Toxicology Devices Panel
March 18-19, June 17-18, October 21-22
3014512514Dental Products Panel
February 11, May 6, June 17, September 16, December 9
3014512518Ear, Nose, and Throat Devices Panel
February 24, May 19, August 18, November 17
3014512522Gastroenterology-Urology Devices Panel
March 20, October 15
3014512523General and Plastic Surgery Devices Panel
February 26-27, June 9-10, October 15-16
3014512519General Hospital and Personal Use Devices Panel
March 25-26, July 29-30, October 21-22
3014512520Hematology and Pathology Devices Panel
April 24, July 17, October 23
3014512515Immunology Devices Panel
October 15-16
3014512516Medical Devices Dispute Resolution Panel
Meetings occur as needed
3014510232Microbiology Devices Panel
February 24-25, September 22-23, October 27-28
3014512517Molecular and Clinical Genetics Panel
April 15, October 5-6
3014510231Neurological Devices Panel
February 26-27, May 14-15, September 17-18, December 2-3
3014512513Obstetrics and Gynecology Devices Panel
February 5-6, May 14-15, August 13-14, November 12-13
3014512524Ophthalmic Devices Panel
February 12-13, May 14-15, September 24-25,November 19-20
3014512396Orthopaedic and Rehabilitation Devices Panel
February 3-4, April 14-15, June 9-10, August 11-12, October 15-16, December 1-2
3014512521Radiological Devices Panel
February 18, May 12, August 4, November 17
3014512526National Mammography Quality Assurance Advisory Committee
November 4-5
3014512397Technical Electronic Product Radiation Safety Standards Committee
No meeting tentatively scheduled for 2009
3014512399CENTER FOR FOOD SAFETY AND APPLIED NUTRITIONFood Advisory Committee
May 20-21
3014510564CENTER FOR VETERINARY MEDICINEVeterinary Medicine Advisory Committee
April 14
3014512548NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)Science Advisory Board to NCTR
November 17-18
3014512559
 Dated: December 24, 2008. Randall W. Lutter, Deputy Commissioner for Policy.


[FR Doc. E9-451 Filed 1-12-09; 8:45 am] BILLING CODE 4160-01-S